Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation
Akira Nifuji1, Hisashi Ideno, Yoshio Ohyama
1National Institute of Radiological Sciences, Chiba, Japan. nifuji-a@tsurumi-u.ac.jp
Abstract:
Mitogen-activated protein kinases (MAPKs) regulate proliferation and differentiation in osteoblasts. The vertebral homologue of nemo, nemo-like kinase (NLK), is an atypical MAPK that targets several signaling components, including the T-cell factor/lymphoid enhancer factor (TCF/Lef1) transcription factor. Recent studies have shown that NLK forms a complex with the histone H3-K9 methyltransferase SETDB1 and suppresses peroxisome proliferator-activated receptor (PPAR)-gamma:: action in the mesenchymal cell line ST2. Here we investigated whether NLK regulates osteoblastic differentiation. We showed that NLK mRNA is expressed in vivo in osteoblasts at embryonic day 18.5 (E18.5) mouse calvariae. By using retrovirus vectors, we performed forced expression of NLK in primary calvarial osteoblasts (pOB cells) and the mesenchymal cell line ST2. Wild-type NLK (NLK-WT) suppressed alkaline phosphatase activity and expression of bone marker genes such as alkaline phosphatase, type I procollagen, runx2, osterix, steopontin and osteocalcin in these cells. NLK-WT also decreased type I collagen protein expression in pOB and ST2 cells. Furthermore, mineralized nodule formation was reduced in pOB cells overexpressing NLK-WT. In contrast, kinase-negative form of NLK (NLK-KN) did not suppress or partially suppress ALP activity and bone marker gene expression in pOB and ST2 cells. NLK-KN did not suppress nodule formation in pOB cells. In addition to forced expression, suppression of endogenous NLK expression by siRNA increased bone marker gene expression in pOB and ST2 cells. Finally, transcriptional activity analysis of gene promoters revealed that NLK-WT suppressed Wnt1 activation of TOP flash promoter and Runx2 activation of the osteocalcin promoter. Taken together, these results suggest that NLK negatively regulates osteoblastic differentiation.
Insights
Nemo-like kinase (NLK) negatively regulates osteoblastic differentiation. Overexpressing NLK in osteoblasts suppresses bone marker gene expression and reduces mineralized nodule formation, indicating its role in bone development.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mitogen-activated protein kinases (MAPKs) are crucial for osteoblast proliferation and differentiation.
- Nemo-like kinase (NLK), an atypical MAPK, interacts with signaling components like TCF/Lef1 and SETDB1, influencing gene expression.
- Previous research indicated NLK's role in suppressing PPAR-gamma activity in mesenchymal cells.
Purpose of the Study:
- To investigate the role of Nemo-like kinase (NLK) in regulating osteoblastic differentiation.
- To determine if NLK expression impacts key markers of bone formation.
- To elucidate the mechanism by which NLK influences osteogenesis.
Main Methods:
- NLK mRNA expression analysis in mouse calvariae osteoblasts.
- Forced expression of wild-type (NLK-WT) and kinase-negative (NLK-KN) NLK in primary osteoblasts (pOB) and ST2 cells using retrovirus vectors.
- Small interfering RNA (siRNA) to suppress endogenous NLK expression.
- Assays for alkaline phosphatase activity, bone marker gene expression (Alp, Col1a1, Runx2, Osterix, Spp1, Osteocalcin), type I collagen protein levels, and mineralized nodule formation.
- Reporter gene assays to analyze promoter activity (TOP flash and osteocalcin promoter).
Main Results:
- NLK mRNA is expressed in osteoblasts during mouse development (E18.5).
- Overexpression of NLK-WT significantly suppressed alkaline phosphatase activity, bone marker gene expression, type I collagen protein levels, and mineralized nodule formation in pOB and ST2 cells.
- Kinase-negative NLK (NLK-KN) showed no or partial suppression of these osteoblastic markers.
- siRNA-mediated suppression of endogenous NLK increased bone marker gene expression.
- NLK-WT suppressed Wnt1-activated TOP flash promoter activity and Runx2-activated osteocalcin promoter activity.
Conclusions:
- Nemo-like kinase (NLK) acts as a negative regulator of osteoblastic differentiation.
- NLK influences osteogenesis by suppressing key bone formation markers and inhibiting Wnt/TCF and Runx2 signaling pathways.
- These findings highlight NLK as a potential therapeutic target for modulating bone formation.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Cell Specific Gene Expression
Cell Specific Gene Expression
iPS Cell Differentiation
Receptor Tyrosine Kinases


